Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Faeth Therapeutics

Request full access

Faeth Therapeutics, Inc. is customizing diets for oncology patients, based on their tumor genomics

San Francisco, United StatesFounded 2019Biotech & Life Sciences

About Faeth Therapeutics

Faeth Therapeutics is a pioneering startup in the healthcare sector, specifically in the field of cancer treatment. The company operates in the market of cancer therapeutics, serving patients suffering from various types of tumors. Faeth's unique approach involves the use of metabolic data to develop safer and more effective therapies.

The company's proprietary MetabOS platform is a groundbreaking innovation that offers new insights into drug-nutrient interactions across all tumor types. This platform is used to optimize the metabolic process through diet, thereby introducing a novel method of treating cancer. Faeth pairs its anti-cancer drugs with precision diets or other metabolism-focused drugs to enhance the overall treatment outcomes and reduce toxicity.

Faeth's business model is centered around its therapeutic programs that combine anti-cancer drugs with precision diets. These diets are specifically designed to increase the efficacy of the drugs and decrease their adverse effects. This makes Faeth's treatments more potent against tumors and easier for patients to tolerate. The company generates revenue by offering these unique therapeutic programs to patients.

Faeth also encourages patients to participate in clinical trials, which not only helps in the development and refinement of their therapies but also provides patients with access to potentially life-saving treatments.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2019
Headquarters
San Francisco, United States
Employees
29
Open positions
22
Dealroom signal
76.5/100
Industry
Health
Sub-industry
BioTechnology, Health Platform
Sector
Biotech & Life Sciences, Biotechnology, Chronic Disease, Spinout, Digital Therapeutics, Biotech and Pharma, DT and LS, science-based
Business model
SaaS
Client focus
B2B

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Feb 2026 $0 — Sensei Biotherapeutics ↗
LATE VCOther financing Oct 2025 $25M $235M Cantos Ventures · Avicella Capital · Khosla Ventures · B Capital ↗
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Faeth Therapeutics website traffic

Latest recorded traffic for Faeth Therapeutics is 5.6K monthly website visits, up 154.5% over the last three months. Faeth Therapeutics's team grew 3.6% over the past year.

Latest monthly visits5.6K 3-month web change+154.5% 1-year team growth+3.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Faeth Therapeutics in the San Francisco ecosystem

Live from Dealroom

The Faeth Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed7 investors entered at this stage

  • Future Ventures
  • Unshackled
  • AgFunder
  • Cantos Ventures
  • S2G Investments
  • KdT Ventures
  • Digitalis Ventures

Series A1 investor entered at this stage

Series B and later3 investors entered at this stage

Other known investors3 additional known investors

  • Cornell Tech
  • Cornell University
  • Sensei Biotherapeutics
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States50%
🇮🇳 India35%
🇬🇧 United Kingdom10%
🇸🇪 Sweden5%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Faeth Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Faeth Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.